Navigation Links
Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
Date:5/14/2009

- Shareholders Approve All Items -

LAKE FOREST, Ill., May 14 /PRNewswire-FirstCall/ -- Hospira, Inc. (NYSE: HSP), a leading global specialty pharmaceutical and medication delivery company, today held its 2009 Annual Meeting of Shareholders in Denver, Colo. The agenda included votes on three items and an update on the company's five-year progress and its strategy going forward.

"We have made significant progress since becoming a public company in 2004, a testament to the strong foundation we have established and the disciplined execution of our strategies," said Christopher B. Begley, chairman and chief executive officer. "Our commitment to providing high quality, innovative solutions that meet customer needs, along with our increased focus on driving sustainable growth, position Hospira for continued success."

During the annual meeting, shareholders:

  • elected the following directors: Christopher B. Begley, Barbara L. Bowles, Roger H. Hale and John C. Staley, all Class II directors whose terms expire in 2012; and Heino von Prondzynski, a Class III director whose term expires in 2010;
  • ratified the appointment of Deloitte & Touche LLP as Hospira's auditors for 2009; and
  • approved amendments to Hospira's long-term incentive plan.

A full description of the above matters was included in Hospira's proxy statement related to the meeting. The proxy statement is available on Hospira's Web site at www.hospirainvestor.com, as are Begley's remarks made at today's meeting.

About Hospira

Hospira, Inc. is a global specialty pharmaceutical and medication delivery company dedicated to Advancing Wellness(TM). As the world leader in specialty generic injectable pharmaceuticals, Hospira offers one of the broadest portfolios of generic acute-care and oncology injectables, as well as integrated infusion therapy and medication management solutions. Through its products, Hospira helps improve the safety, cost and productivity of patient care. The company is headquartered in Lake Forest, Ill., and has more than 14,000 employees. Learn more at www.hospira.com.


'/>"/>
SOURCE Hospira, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hospira to Present at Bank of America and Merrill Lynch 2009 Health Care Conference May 13
2. Hospira Launches Biologics Clock and Web Resource to Raise Awareness of Potential Biogenerics Impact
3. Hospira Reports First-Quarter 2009 Results
4. Hospira to Host Conference Call for First-Quarter 2009 Results
5. Hospira to Present at Cowen and Companys 29th Annual Health Care Conference March 17
6. Hospira Expands Board of Directors
7. Hospira Reports Fourth-Quarter and Full-Year 2008 Results
8. Hospiras Precedex(R) Phase IV Study Published in the Journal of the American Medical Association
9. Hospira to Host Conference Call for Fourth-Quarter 2008 Results and 2009 Projections
10. Hospira to Present at J.P. Morgans 27th Annual Healthcare Conference January 14
11. Hospira Names Ken Meyers to Lead Human Resources
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2017)... ... January 22, 2017 , ... Zifam Pinnacle, an Australian company dedicated ... met with big-name retail buyers at the January ECRM Trade Show in Hilton Head, ... the utmost safety standards in all of its creations to help create a more ...
(Date:1/21/2017)... ... ... Salveo for life, a company that distributes an effervescent lime-flavored drink called ... part of its presence to expand its market reach. , Using a formula developed ... nasty toxins as a result of drinking alcohol, eliminating those toxins quickly, whilst supporting ...
(Date:1/21/2017)... ... January 21, 2017 , ... ... Dianne Travis-Teague, the electrifying line-up of events for its annual meeting “Coming Home ... and community. “Coming Home 2017” will be held on Friday January 27 ...
(Date:1/21/2017)... ... January 21, 2017 , ... The Nobel ... Dan Holtzclaw in media for its creos™ line of bone regenerative products. ... Holtzclaw in which he utilizes creos™ allo.gain™ bone graft for a variety of ...
(Date:1/20/2017)... ... 20, 2017 , ... Source Vitál Apothecary, a skin and body care company ... the company had a successful visit to the 2017 ECRM Diet, Vitamin & Sports ... work in the nutritional, sports and health industries a chance to meet in private ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... 2017 Many patients don,t realize that they ... a pharmacy just a few blocks away charges only ... problem Medicationdiscountcard.com has created a price comparison ... much their medication will cost at most nearby pharmacies. ... Medicationdiscountcard.com takes all of the ...
(Date:1/19/2017)...  Abaxis, Inc. (NasdaqGS: ABAX ), a ... consumables for the medical and veterinary markets worldwide, has ... for the third quarter fiscal year 2017, ended December ... ET on Thursday, January 26, 2017.  The Company will ... 2017 after the market closes on Thursday, January 26, ...
(Date:1/19/2017)... 19, 2017   Science Exchange , the leading ... that the first five replication studies from the ... published in eLife today. Despite intense scrutiny around ... practical evaluation of reproducibility rates that may identify ... other assessments of reproducibility, the results of this ...
Breaking Medicine Technology: